retatrutide phase 2 trial type 2 diabetes weight loss 2024 ESC 2024: improves lipid and cardiovascular risk profile in II Phase 2 trial results demonstrate

Although GLP-1 medications can prove useful in helping one lose weight, they are even more effective when used in combination with other medical weight loss options

Because of the risk of low blood sugar, Shah says, its really important to work with a doctor on dosing of both the GLP-1 and insulin

Liraglutide (Saxenda) a GLP-1 receptor agonist licensed for weight management, with a more modest but clinically meaningful effect on body weight

Both the Wegovy pill and Foundayo start at $149 per month for self-pay patients at the lowest dose, compared to injectables that can exceed $1,300 per month without insurance